A naukri.com initiative
Bioengineer
2d
296
Image Credit: Bioengineer
UT Health San Antonio Neurologists Pioneer Adaptive Deep Brain Stimulation for Tailored Patient Care
- UT Health San Antonio neurologists have introduced an adaptive deep brain stimulation (DBS) system that customizes treatment based on continuous symptom monitoring, marking a groundbreaking advancement in neurology.
- This innovative technology autonomously adjusts electrical impulses in real time, offering personalized therapy for patients with movement disorders like Parkinson’s disease, dystonia, epilepsy, and essential tremors.
- Unlike traditional DBS systems requiring manual adjustments, this adaptive technology developed by Medtronic revolutionizes patient care by responding dynamically to symptom changes without the need for frequent clinic visits.
- Dr. Okeanis Vaou highlights the system's ability to enhance patient quality of life by adapting stimulation levels based on symptom severity, ensuring timely and tailored therapy delivery.
- The team at UT Health San Antonio, including Dr. Vaou and other clinical assistants, has been at the forefront of implementing this cutting-edge technology, showcasing a commitment to advancing patient care through state-of-the-art solutions.
- The adaptive DBS system offers improved patient engagement and treatment adherence, with activations during routine office visits typically taking about 20 minutes to an hour, facilitating a more hands-on approach to care.
- Dr. Alexander Papanastassiou notes the transformative capabilities of the new system, which self-regulates based on real-time neurological feedback, eliminating the need for manual recalibration and enhancing patient outcomes.
- Initial studies suggest that the adaptive DBS technology not only effectively manages symptoms but also significantly enhances overall patient quality of life by reducing symptom fluctuations, leading to more stable lives for individuals with chronic movement disorders.
- This innovation also aligns with broader research initiatives at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, emphasizing the integration of cutting-edge technology to improve patient outcomes and advance neurology.
- The adaptive DBS system promises a future of more consistent therapy delivery with rechargeable options lasting up to 15 years, reducing interruptions in treatment and providing a seamless experience for patients with movement disorders.
Read Full Article
17 Likes
For uninterrupted reading, download the app